210 related articles for article (PubMed ID: 14583473)
1. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.
Davol PA; Bagdasaryan R; Elfenbein GJ; Maizel AL; Frackelton AR
Cancer Res; 2003 Oct; 63(20):6772-83. PubMed ID: 14583473
[TBL] [Abstract][Full Text] [Related]
2. p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
Frackelton AR; Lu L; Davol PA; Bagdasaryan R; Hafer LJ; Sgroi DC
Breast Cancer Res; 2006; 8(6):R73. PubMed ID: 17196107
[TBL] [Abstract][Full Text] [Related]
3. p66 Shc tumor levels show a strong prognostic correlation with disease outcome in stage IIA colon cancer.
Grossman SR; Lyle S; Resnick MB; Sabo E; Lis RT; Rosinha E; Liu Q; Hsieh CC; Bhat G; Frackelton AR; Hafer LJ
Clin Cancer Res; 2007 Oct; 13(19):5798-804. PubMed ID: 17908971
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential.
Jackson JG; Yoneda T; Clark GM; Yee D
Clin Cancer Res; 2000 Mar; 6(3):1135-9. PubMed ID: 10741744
[TBL] [Abstract][Full Text] [Related]
5. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
6. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas.
Lee MS; Igawa T; Chen SJ; Van Bemmel D; Lin JS; Lin FF; Johansson SL; Christman JK; Lin MF
Int J Cancer; 2004 Feb; 108(5):672-8. PubMed ID: 14696093
[TBL] [Abstract][Full Text] [Related]
7. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
[TBL] [Abstract][Full Text] [Related]
9. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
10. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
11. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.
Veeramani S; Igawa T; Yuan TC; Lin FF; Lee MS; Lin JS; Johansson SL; Lin MF
Oncogene; 2005 Nov; 24(48):7203-12. PubMed ID: 16170380
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
13. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
15. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
16. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
17. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Li HC; Cao DC; Liu Y; Hou YF; Wu J; Lu JS; Di GH; Liu G; Li FM; Ou ZL; Jie C; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2004 Nov; 88(1):75-85. PubMed ID: 15538048
[TBL] [Abstract][Full Text] [Related]
20. Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
Casalini P; Carcangiu ML; Tammi R; Auvinen P; Kosma VM; Valagussa P; Greco M; Balsari A; Ménard S; Tagliabue E
Clin Cancer Res; 2008 Jan; 14(1):25-31. PubMed ID: 18172248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
